Category: misconduct investigations

Four papers by former Wayne State researcher retracted after ORI report

Teresita L. Briones
Teresita L. Briones

Retractions have been published for four papers authored by former Wayne State University professor, Teresita L. Briones, after an April ORI report found evidence of misconduct in the articles.

Investigators found that Briones had “intentionally, knowingly, and recklessly engaged in research misconduct by falsifying and/or fabricating data.” They flagged five papers and three grant applications that contained false data.

As a result of their findings, four out of the five papers have been retracted, and the editors of the remaining journal say they are looking into the last paper.

Continue reading Four papers by former Wayne State researcher retracted after ORI report

Nutrition researcher Chandra loses libel case against CBC

CBCThe self-proclaimed “father of nutritional immunology,” Ranjit Kumar Chandra, has lost a libel lawsuit against the Canadian Broadcasting Company (CBC).

The suit was in response to a 2006 three-part documentary from the CBC, which examined allegations of fraud against the former Memorial University researcher.

After the 58-day trial, the Ontario Superior Court of Justice “ruled in favour of CBC, on the grounds that the words in the broadcast were true,” according to CBC producer Lynn Burgess: Continue reading Nutrition researcher Chandra loses libel case against CBC

Judge dismisses cardiac stem cell researchers’ lawsuit against Harvard

Piero Anversa
Piero Anversa

A Massachusetts judge has dismissed a lawsuit by researchers who argued that an investigation by Harvard cost them job offers.

Last year, Piero Anversa, a stem cell researcher at the Brigham & Women’s Hospital, and a colleague, Annarosa Leri, sued Harvard over an investigation into their work that they claim damaged their reputations: Continue reading Judge dismisses cardiac stem cell researchers’ lawsuit against Harvard

“Falsified” data shelve two more drug studies from discredited U Colorado student

The authors of a pair of papers in Molecular Pharmaceutics are retracting them following an investigation at the University of Colorado Denver, which found a graduate student had faked data.

Rajendra Kadam was a prominent member of the Research lab of Uday B. Kompella, until the investigation revealed earlier this year that he had “falsified” data from a liquid chromatography-mass spectroscopy (LC-MS) machine for years.

So far, we’ve found four retractions (including the latest two) and one expression of concern for Kadam. There may be more on the way: Continue reading “Falsified” data shelve two more drug studies from discredited U Colorado student

Oregon grad student admits to faking data in four neuroscience papers

oriweb_logoA graduate student at the University of Oregon in Eugene has admitted to faking data that appeared in four published papers in the field of visual working memory, according to the Office of Research Integrity.

David Anderson’s supervisor at the time was Edward Awh, who has since moved to the University of Chicago.

Anderson told Retraction Watch that the misconduct stemmed from “an error in judgment”:

Continue reading Oregon grad student admits to faking data in four neuroscience papers

Penn State postdoc faked data in cancer manuscript

oriweb_logoA former postdoctoral fellow at Penn State University faked numerous data and analyses in a manuscript submitted to Molecular Cancer Research, according to the Office of Research Integrity (ORI).

In a notice released today, the ORI found Julie Massè: Continue reading Penn State postdoc faked data in cancer manuscript

UPitt investigation brings total retraction count to four for pair of cancer researchers

Journal of Biological Chemistry1An official inquiry by the University of Pittsburgh has led to two more retractions for a pair of cancer researchers, Tong Wu and Chang Han. By our count, the pair now have four retractions under their belt, all the result of the university investigation.

The Journal of Biological Chemistry published the notices earlier this month, after it was discovered the papers contained cropped panels, among other issues. Importantly, the two papers appear to even have shared some data.

One 2006 paper, “Modulation of Stat3 Activation by the Cytosolic Phospholipase A2α and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway,” investigated the molecular actors in cancer growth, such as overexpression of cyclooxygenase-2 (COX-2). It has been cited 34 times, according to Thomson Scientific’s Web of Knowledge. Here’s the notice:

Continue reading UPitt investigation brings total retraction count to four for pair of cancer researchers

“There has been negligence”: Biologist banned for one year by German funding agency

4a656e732e43687269737469616e2e53636877616d626f726e534348574a3133313830
Jens Christian Schwamborn

As a consequence for academic “negligence” which resulted in two retractions, biologist Jens Schwamborn was banned from seeking funding from German funding agency DFG for one year.

The ban — which ended in March, 2015 — was the result of an investigation by DFG and the University of Münster, which reviewed the issues that led to retractions of two papers about neuron development, one in The EMBO Journal, and another in the Journal of Biological Chemistry. 

Here’s the official statement on the ban, sent to us by Head of Communications Britta Schlüter at the University of Luxembourg, where Schwamborn now works:

Continue reading “There has been negligence”: Biologist banned for one year by German funding agency

Former FDA chemist who admitted taking bribe wins back right to work in drug industry, 20 years later

FDAMore than 20 years after the U.S. Food and Drug Administration permanently debarred a former chemist for accepting bribes — and a puzzling 17 years after he asked for a pardon after helping the agency prosecute other cases — the FDA is lifting its debarment.

In 1994, chemist David J. Brancato:

…was permanently debarred from providing services in any capacity to a person with an approved or pending drug product application…

This suggests that he wasn’t even able to work with anyone with an FDA-approved product.

The reason the debarment was lifted?

Continue reading Former FDA chemist who admitted taking bribe wins back right to work in drug industry, 20 years later

Gut paper retracted after university review says “figures cannot be validated by original data”

IBDA biologist at Case Western Reserve University School of Medicine in Ohio has retracted a paper from Inflammatory Bowel Diseases after a university review found the figures within it could not be “validated by original data.”

The 2010 paper, “Elevated IL-13Rα2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway,” concerns the elevated expression and role of an inflammatory protein in colon cancer cells.

According to the notice, corresponding author and biologist Alan Levine — who recently received a $3.9 million Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse — requested the retraction.

Here’s the full notice: Continue reading Gut paper retracted after university review says “figures cannot be validated by original data”